Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Industry buzz

China: SFDA approves two new cosmetic ingredients

After a long public consultation period China’s State Food and Drug Administration (SFDA) recently approved two new cosmetic ingredients:

  • PM-Lysine (INCI name: Polymethacryloyl Lysine, CAS: 543700-70-5), and,

PM-Lysine

PM-Lysine

  • Nivitol (INCI name: Dimethoxytolyl Propylresorcinol, CAS: 869743-37-3).

Nivitol

Nivitol

These substances are the first to be approved by the SFDA since the agency took over responsibilities of approving new cosmetic ingredients from the Ministry of Health in 2008.

The original text of the SFDA’s notification can be found here:

http://www.sda.gov.cn/WS01/CL0027/69982.html

V.G.

© 2012 - Premium Beauty News - www.premiumbeautynews.com
latest news
Focus
spip-vignette

A new trade show dedicated to clean beauty in London

Dubbed Clean Beauty in London the new trade show intends to gather experts, scientists, suppliers, brands, influencers and journalists under one roof “to build the future of clean beauty.” Taking place on October 12 & 13, 2020 at The Brewery, located at 52 Chiswell Street at the heart of London, the event aims to encourage (...)

read more
job opportunities
Experts’ views
India emerges as the next beauty giant

Asia Cosme Lab
India emerges as the next beauty giant

Thanks to a growing young population (first youth population in the world) and the emergence of a vast middle class, as well as a higher Internet connection from both urban and rural areas, India is set to emerge as the next beauty giant after China. Asia Cosme Lab took a deep dive in the fascinating Indian market, where both (...)

read more
Webinars
E-shop - latest publications
Safety of perfumes and cosmetics. Belarus, Kazakhstan and Russia
200.00 € excl. tax
Regulations on the registration of cosmetic products in China
200.00 € excl. tax
Regulations on the registration of cosmetic products in China (part2)
95.00 € excl. tax
Go to top ↑

Features

We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies
close